InvestorsHub Logo
Followers 25
Posts 3482
Boards Moderated 0
Alias Born 08/21/2014

Re: None

Wednesday, 07/27/2016 8:17:31 AM

Wednesday, July 27, 2016 8:17:31 AM

Post# of 458321
Anavex is not worthy of mention by AF. Don't know if this is a good or a bad thing ;)

Most Alzheimer's research is based on the theory that clumps of a different protein known as beta amyloid cause the disease, although no one has yet developed a drug effective enough to validate this hypothesis. Pfizer (PFE) , Johnson & Johnson (JNJ) , Elan (ELN) and other drug companies have tried.

Biogen (BIIB) and Eli Lilly (LLY) are still trying. The companies are conducting separate phase III studies of competing drugs which target the elimination of beta amyloid from the brains of Alzheimer's patients.

"It's important for the Alzheimer's field that tau therapies continue to be developed," he said.

J&J and AbbVie ( ABBV) also have tau drugs in their Alzheimer's research pipelines.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News